Ariel Sotolongo
Adult Health · Miami, FLNPI 1265862072
Payments from drug & device makers
Across 193 payments — averaging $28.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sun Pharmaceutical Industries Inc.$611
- UCB, Inc.$563
- Merz North America, Inc.$486
- Johnson & Johnson$360
- Lilly USA, LLC$309
- plus $2K from 11 others
What the payments were for
- Food & beverage$5,17296%
- Education$2334%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 70 | $1,533 |
| Sun Pharmaceutical Industries Inc. | 20 | $611 |
| UCB, Inc. | 28 | $563 |
| Merz North America, Inc. | 9 | $486 |
| Johnson & Johnson | 16 | $360 |
| Lilly USA, LLC | 6 | $309 |
| Janssen Scientific Affairs, LLC | 2 | $270 |
| Almirall LLC | 4 | $259 |
| E.r. Squibb & Sons, L.L.C. | 10 | $238 |
| Novartis | 10 | $235 |
| Incyte Corporation | 5 | $222 |
| Pfizer | 5 | $114 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $89 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Teva Pharmaceuticals USA, Inc. | 1 | $32 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,405 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Taltz AutoinjectorIxekizumab | 12 | $78,480 |
Paid to pharmacies, not to this prescriber.
Other adult health in Miami
- Norma SolisMiami$150K
- Jeffrey HernandezMiami$122K
- Kristen NievesMiami$16K
- Jose ChamorroMiami$15K
- Wendy KaysMiami$13K
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Ashley PontenbergWinter Park$136K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.